BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) ...
StemCyte announces positive results from phase IIa trial of HPC, cord blood for treating post-Covid syndrome: Baldwin Park, California Monday, December 23, 2024, 17:00 Hrs [IST] S ...
You could have diabetes and not know it. This chronic disease, in which blood sugars are elevated because the pancreas doesn't make enough or any insulin, is one of the most common chronic ...